Circulation. 1997;95:265-272
(Circulation. 1997;95:265-272.)
© 1997 American Heart Association, Inc.
Survivors of Out-of-Hospital Cardiac Arrest With Apparently Normal Heart
Need for Definition and Standardized Clinical Evaluation
Consensus Statement of the Joint Steering Committees of the Unexplained Cardiac Arrest Registry of Europe* and of the Idiopathic Ventricular Fibrillation Registry of the United States
Correspondence to Silvia G. Priori, MD, PhD, FESC, Molecular Cardiology Unit, Cardiovascular Laboratories, Fondazione S. Maugeri, IRCCS, and Department of Cardiology, Policlinico S. Matteo, IRCCS, Piazzale Golgi 2, 27100 Pavia, Italy.
 |
Abstract
|
|---|
Background A wide variety of structural abnormalities are associated
with the vast majority of cardiac arrests. However, there is
no evidence of structural heart disease in

5% of victims of
sudden death, indicating that cardiac arrest in the absence
of organic heart disease is more common than previously recognized.
The risk of recurrence and the acute and long-term response
to therapy are important but unanswered questions. Data from
the small series reported so far are of limited value because
of the lack of uniform criteria to define and diagnose idiopathic
ventricular fibrillation (IVF).
Methods and Results This report originates from a Consensus Conference convened by the Steering Committees of the European (UCARE) and North American (IVF-US) Registries on IVF under the auspices of the Working Group on Arrhythmias of the European Society of Cardiology. Its objective is to provide a unified definition of IVF and to outline the investigations necessary to make this diagnosis. Minimal diagnostic tests for the exclusion of an underlying structural heart disease include noninvasive (blood biochemistry, physical examination and clinical history, ECG, exercise stress test, 24-hour Holter recording, and echocardiogram) and invasive (coronary angiography, right and left ventricular cineangiography, and electrophysiological study) examinations. Programmed electrical stimulation, ventricular biopsy, and ergonovine test during coronary angiography are recommended but not mandatory.
Conclusions It is recognized that despite careful evaluation, conditions such as focal cardiomyopathy, myocarditis, or fibrosis and transient electrolyte abnormalities may remain silent. Therefore, patients should undergo careful follow-up, with noninvasive tests repeated every year. The existence of a unified terminology will allow meaningful comparison of data collected by different investigators and will thus contribute to a better understanding of IVF.
Key Words: fibrillation death, sudden arrhythmia diagnosis
 |
Introduction
|
|---|
More than 90% of sudden cardiac deaths occur in patients with
known or previously unrecognized preexisting coronary heart
disease or cardiomyopathies. Among the remainder, it has become
evident that sudden arrhythmic death occurs with sufficient
frequency in patients with an apparently normal heart to warrant
the attention of the cardiological community. This is further
supported by the tendency for such fatal events to occur in
special groups, such as young, active, and otherwise healthy
individuals.
The most pressing questions about this entity concern the risk of recurrence, the acute and long-term responses to the various therapies currently used, and the intriguing possibility that in some patients VF may represent the first clinical sign of structural disease that becomes manifest only several years later among survivors.
The Working Group on Arrhythmias of the European Society of Cardiology recognized the clinical relevance of these questions and in 1992 formally established a prospective long-term registry of this clinical entity with the goal of addressing this problem.1 This project is named UCARE and has already enrolled more than 160 patients who survived an episode of IVF. Preliminary data2 3 suggest that IVF is associated with a high (25% to 30%) risk of recurrence of cardiac arrest. In 1994, a group of investigators in the United States decided to initiate a similar registry (IVF-US).
A clear and unified definition of "an apparently normal heart" is essential to avoid the misdiagnosis of IVF in a survivor of a cardiac arrest due to a specific clinical entity for which an appropriate treatment may have already been established. Accordingly, the Steering Committees of the European and the American registries formed a panel to establish the criteria necessary for the diagnosis of "cardiac arrest with an apparently normal heart." The meeting stimulated the creation of the present document, whose main objective is to propose a set of standardized diagnostic criteria.
 |
Background
|
|---|
A wide variety of structural abnormalities are associated with
the vast majority of cardiac arrests.
4 However, it is necessary
to deal with the fact that there are also functional causes
not associated with pathological anatomic changes.
Sudden arrhythmic death in the absence of structural heart disease is an uncommon event. However, data from large series of patients resuscitated from cardiac arrest and necropsy data from victims of sudden death indicate that there is no evidence of structural heart disease in
5% of victims of sudden death.5 6 7 8 9 10 11 12 Thus, cardiac arrest in the absence of structural heart disease may be more common than previously recognized. This subgroup of survivors of out-of-hospital cardiac arrest deserves to be carefully evaluated to define their optimal long-term management and outcome,13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 because their survival is largely related to potentially controllable electrophysiological disturbances, rather than limited by the competing risk of advanced myocardial disease.30
The data already available in UCARE, based on >160 patients, represent the largest collective experience on IVF. According to the UCARE investigators, after 3 years from cardiac arrest, IVF patients have 30% recurrence of VF, syncope, and cardiac arrest, and prevention of recurrence is inadequate with the use of antiarrhythmic agents, including ß-blockers.2 These data are at variance with the experience of Belhassen and Viskin,31 who reported favorable effects of sodium channel blockers, but they are in agreement with previous observations28 29 suggesting a high recurrence rate of malignant tachyarrhythmias in IVF survivors and raising the possibility that IVF patients should be considered candidates for an implantable defibrillator.2 It is therefore important to produce guidelines to define the criteria to separate IVF from other conditions in which VF may be the first manifestation of the disease.
 |
Definitions
|
|---|
Several terms have been proposed to describe those patients
who survive an episode of ECG-documented VF with an apparently
normal heart. The language used to define such patients is not
merely semantic; it has operational connotations for both clinical
and research purposes.
Primary electrical disease implies that there is no recognizable structural heart disease to account for the arrhythmic event and that an electrophysiological mechanism is solely responsible for the arrhythmic episode. The limitation of this definition is that it is impossible to exclude causes such as transient autonomic abnormalities as the initiating mechanism for the arrhythmia. Moreover, this definition could be extended to atrial arrhythmias such as lone atrial fibrillation and to benign idiopathic arrhythmias such as isolated premature ventricular complexes and idiopathic nonsustained VT.
Arrhythmic death without identifiable heart disease is another term that reflects the lack of identification of a cardiac disease. It has the advantage of considering that a minimal structural abnormality can be responsible for the development of the arrhythmia; however, "arrhythmic death" may also include arrhythmias other than VF, such as sinus arrest or complete AV block.
IVF is the terminology that best acknowledges our current inability to identify a causal relationship between the clinical circumstance and the arrhythmia. The advantage of this definition is that the term IVF does not imply that the heart of the patient is completely free of structural or definable functional abnormalities but simply that, if an abnormal finding (such as first-degree AV block or paroxysmal atrial fibrillation) is present, it is not considered responsible for the VF.
Thus, in the absence of clinical or laboratory findings that could account for the occurrence of major arrhythmic events, the diagnosis of IVF can be made once a survivor of cardiac arrest has been extensively studied.
These considerations emphasize the concept that there may be no distinct and fixed border between normal and frankly abnormal. Moreover, the border may change over time, and new data emerging on membrane-based functional32 33 or structural abnormalities34 35 may ultimately provide more specifically defined explanations.
A disease is "idiopathic" because present knowledge has not yet allowed identification of the underlying cause. Eventually, the cause of most idiopathic disorders will be known. For example, the LQTS, which was considered idiopathic until the three genes responsible for most cases were identified,36 37 38 39 is no longer so. Thus, IVF is an appropriate "initial" or "working" diagnosis that reflects our current inability to establish a link between clinical information obtained by detailed invasive or noninvasive examinations and a life-threatening arrhythmic event.
We include in the IVF group only individuals with a documented VF, even though it cannot be ruled out that the arrhythmic episode might have started as VT or even asystole. We believe that, despite being an arbitrary distinction, this criterion originates from the idea that it is the degeneration into VF that represents the common denominator for this group of patients.
 |
Evaluation of the Arrhythmogenic Substrate in Survivors of Cardiac Arrest
|
|---|
IVF is a diagnosis of exclusion. Therefore, it is of pivotal
importance to define the conditions that have to be excluded
as well as the most appropriate techniques for excluding them.
There is no need to exclude every cardiac abnormality but rather only those conditions known to be associated with sudden death.
 |
Use and Abuse of Drugs
|
|---|
Before any medical or invasive investigation is undertaken,
it is critical to obtain a careful clinical history. Indeed,
a link between the use of pharmacological substances and the
development of VF may be suspected simply by questioning the
patient with regard to exposure to substances or drugs in the
days before the index event. Many drugs are known to favor development
of torsade de pointes: among these are quinidine, phenothiazines,
antibiotics like erythromycin and other macrolides,
40 and antihistamines,
41 either alone or in combination with antifungal drugs of the
"conazole" type.
42
The link between alcohol abuse and lethal ventricular tachyarrhythmias has been suggested but not conclusively demonstrated. A few studies43 44 45 reported that lethal ventricular arrhythmias may precede signs of alcoholic cardiomyopathy. It is important to obtain urine toxicology in patients suspected of drug abuse.
 |
Ischemic Heart Disease
|
|---|
Coronary angiography is necessary for establishing the presence
or absence of coronary heart disease and to detect congenital
coronary anomalies. Among patients with typical angina pectoris
or with multiple risk factors for ischemic heart disease, the
results of noninvasive tests help to quantify the probability
of ischemic heart disease. However, in the heterogeneous population
of patients with unexplained cardiac arrest whose demographic
and clinical profiles are often quite different from those of
patients at risk for ischemic heart disease, the pretest probability
of coronary artery disease is undefined. Thus, according to
Bayesian theory, results of noninvasive tests such as exercise
stress test and myocardial scintigraphy with thallium may not
be helpful in the diagnostic process.
46 Therefore, it is recommended
that coronary angiography be performed in all patients, of any
age, with unexplained cardiac arrest to establish whether or
not there is ischemic heart disease.
IVF will be excluded in the presence of (1) an unequivocal clinical history of ischemic heart disease, (2) definite evidence of acute myocardial ischemia or necrosis on the 12-lead ECG unless enzyme elevation is due to defibrillation shocks,47 and (3) anatomic alterations in the coronary arterial tree that are considered to be clinically important.
It is reasonable to define a narrowing of
50% in at least one coronary artery as excluding the diagnosis of IVF.15 The significance of minor stenoses with narrowing in the range of 25% to 49% is difficult to assess, because they may be thrombogenic and/or favor coronary spasm. The definition of IVF in these cases must be left to the judgment of the responsible clinician. In this respect, testing for provocation of coronary artery spasm may be important to identify silent myocardial ischemia or atypical symptoms,48 and patients with a positive test should be excluded. Careful follow-up of patients suspected of ischemic heart disease may identify signs and symptoms of ischemia shortly after the index event.
It has been suggested that myocardial perfusion heterogeneity and impaired perfusion reserve may be present in IVF survivors49 ; however, no conclusive data have established a causal link between ventricular tachyarrhythmias and microvascular disease. At present, therefore, there is no indication for routine PET studies to exclude this condition.
Coronary arteries may be "bridged" by muscle bands.50 Although systolic narrowing of normal coronary arteries does not result in myocardial ischemia in most individuals, in the absence of chest pain it is unlikely that bridging is the cause of asymptomatic ischemia precipitating cardiac arrest. When this abnormality is diagnosed or suspected at angiography, however, it is mandatory to exclude by scintigraphy the presence of myocardial ischemia.
 |
Dilated Cardiomyopathy
|
|---|
The conventional diagnosis of myocardial disease depends on
the demonstration of ventricular dilatation and reduced contractile
function by ventriculography or two-dimensional echocardiography,
in the absence of coronary artery disease. Assessment of ventricular
function must be done

48 hours after the arrest, since prolonged
(15 minutes) resuscitation in otherwise healthy subjects produces
myocardial stunning that takes at least 48 hours to recover
and is associated with transient systolic and diastolic dysfunction.
51 In an early phase of the disease, there may be more subtle
features, such as an ejection fraction <50% or mild cavity
enlargement (increase of volumes <20%).
 |
Hypertrophic Cardiomyopathy
|
|---|
Sudden cardiac death is a common initial presentation of hypertrophic
cardiomyopathy, particularly in the young. The clinical diagnosis
in survivors is based on history, physical examination, 12-lead
ECG, and two-dimensional echocardiographic/Doppler evaluation.
52 The majority of individuals who have suffered out-of-hospital
VF from hypertrophic cardiomyopathy will fulfill conventional
diagnostic criteria, eg, unexplained left ventricular hypertrophy.
Occasionally, and particularly in those families with mutations
in the cardiac troponin T gene, the echocardiographic features
do not fulfill current diagnostic criteria.
35 In such instances,
suggestive features such as mild increase in left ventricular
wall thickening, small left ventricular cavity dimensions, incomplete
systolic anterior motion of the mitral valve, or diastolic abnormalities
including atrial enlargement should lead to consideration of
the diagnosis, with particular attention to family history,
symptoms (endurance exercise tolerance), and minor ECG abnormalities
(repolarization changes, intraventricular conduction defects,
abnormal Q waves).
A range of mutations in four different contractile protein genes have been shown to cause disease. It is technically possible to screen the ß-myosin heavy chain, cardiac troponin T, cardiac
-tropomyosin, and myosin-binding protein C genes for mutations. This, however, is still a research procedure and at present cannot be offered as a routine clinical service. The identification of the remaining genes and more cost-effective ways of screening for mutations should in the future lead to a DNA diagnostic that could be applied to survivors of out-of-hospital VF in whom there is diagnostic uncertainty.
 |
Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
|
|---|
The first clinical sign of ARVD, which is also called right
ventricular cardiomyopathy, is often the occurrence of VT of
right ventricular origin, frequently elicited by exercise; subtle
abnormalities of the right ventricle may also be present, and
cardiac arrest may be the presenting clinical manifestation.
53 54 This diagnosis should always be sought among survivors of
cardiac arrest.
55
The histological demonstration of (fibro)-fatty replacement of right ventricular myocardium allows definite diagnosis of right ventricular dysplasia/cardiomyopathy. The disease can be overlooked unless the right ventricle is specifically assessed during imaging studies. An echocardiogram of the right ventricle may reveal hypokinetic areas or dilatation in the free wall of the right ventricle and in the infundibulum. A normal echocardiogram does not exclude the diagnosis of ARVD. Right ventricular cineangiography with 30° right anterior oblique and 60° left anterior oblique views provides the most appropriate way to identify motion abnormalities of the right ventricle. ECG abnormalities such as inverted T waves in V2 and V3 in patients >12 years old without RBBB and prolongation of the QRS (>110 ms) in V2 and V3 have been suggested as major criteria for the diagnosis of ARVD by the Task Force of the Working Group for Myocardial and Pericardial Diseases.53 In the less obvious forms of the disease, the diagnosis is based on the simultaneous presence of a constellation of abnormal findings that, by themselves, would be nondiagnostic. The role of MRI in the diagnosis of ARVD still needs to be defined56 57 ; therefore, this investigation cannot be considered necessary before this diagnosis has been excluded.
In
30% of cases the disease is familial, with an autosomal dominant inheritance; the genetic abnormality has been located in yet unknown genes on chromosome 1458 and chromosome 1.59
 |
LQTS/Prolonged-QT Interval
|
|---|
QT-interval prolongation, history of stress-induced syncope,
and family history are the mainstays for the diagnosis of the
Romano-Ward form of the congenital LQTS.
60 In the presence
of a markedly prolonged QT interval and of typical abnormalities
of T-wave morphology, the diagnosis is rather straightforward.
The problem remains the diagnosis of equivocal cases.
Careful evaluation of the 12-lead ECG is critical. QT and QTc duration and dispersion61 should be assessed. QTc values >440 ms for men and >460 ms for women are considered to be prolonged.62 The diagnosis of questionable LQTS cases is still problematic. Careful evaluation of repeated 12-lead ECGs of the patient and family members and repeated Holter monitoring remain of critical importance. In borderline cases, attention should be paid to identify abnormal T-wave morphologies, such as T-wave alternans63 and notches on the T wave,64 65 and sudden pauses during Holter monitoring60 that may contribute importantly to the diagnosis. An exercise stress test is also required because QT prolongation or T- or U-wave abnormalities may appear during exercise or at its cessation.
The recent identification of three of the genes responsible for LQTS cases36 37 38 39 opens the possibility for genetic diagnosis. However, molecular diagnosis is still largely a research tool.66
Several drugs, including noncardiovascular drugs, prolong the QT interval and cause cardiac arrest40 41 42 ; a complete list of current medications should always be obtained in patients with QT prolongation and cardiac arrest. In addition, electrolyte imbalance, such as hypokalemia or hypocalcemia, can also prolong repolarization. Accordingly, the presence of a prolonged QT interval should be considered a strong factor against the diagnosis of IVF.
 |
Idiopathic Ventricular Tachycardia
|
|---|
Several forms of VT are included in this group, such as verapamil-sensitive
VT,
67 fascicular tachycardia of RBBB configuration with left
or right axis deviation,
68 and right ventricular outflow tract
tachycardia.
69 Irrespective of their site of origin, all these
tachycardias share a benign prognosis.
70 In contrast, several
types of polymorphic idiopathic VT have been described and are
associated with a poor outcome.
71 72 73 They can occur as sporadic
or familial forms and are frequently precipitated by catecholamine
release during physical or emotional stress, although this is
not a consistent feature. The short-coupled variant of torsade
de pointes
73 shares several clinical and ECG characteristics
with those described in idiopathic VF by Belhassen et al.
74 On the other hand, the straightforward relationship between
arrhythmia precipitation and stress, as well as the reproducible
provocation of atrial and ventricular arrhythmias by exercise
or isoproterenol infusion in children with the catecholaminergic
polymorphic VT,
71 merits a separate classification. Patients
with catecholaminergic polymorphic VT have a favorable response
to treatment with ß-blockers, whereas patients with idiopathic
VF or short-coupled torsade de pointes do not.
 |
Sudden Unexplained Nocturnal Death Syndrome
|
|---|
Sudden unexplained nocturnal death syndrome is a sudden unexplained
nocturnal death in young, apparently healthy males
75 76 77 78 of Southeast Asian origin. These deaths are named lai-tai (sleep
death) in Laos, pokkuri (sudden and unexpected death) in Japan,
and bangungut (to rise and moan in sleep) in the Philippines.
Death is unexpected, because the victims are in apparently good
health. The immediate symptoms are onset of agonal respiration
during sleep. Some victims are revived by vigorous cardiac massage
and then reported a sensation of airway obstruction, chest pressure,
and numb or weak limbs. The cause for sudden unexplained nocturnal
death syndrome is still unknown; however, the peculiar geographic
distribution of these patients and the type of symptoms, including
night terrors, nightmares, and nocturnal vocalizations,
77 78 suggest that this diagnosis should be kept separate from IVF.
 |
Ventricular Preexcitation
|
|---|
In patients with presumed IVF, the possibility of an accessory
AV connection should include careful evaluation of the 12-lead
surface ECG for the presence of a delta wave, and an electrophysiological
study is suggested. The latter is important, considering that
antegradely conducting accessory pathways, especially left-sided
pathways, may not be apparent in a 12-lead ECG performed during
sinus rhythm.
79 An electrophysiological study is performed
to identify an accessory AV connection and recognize risk factors
for sudden death
80 (short anterograde refractory period of
the accessory pathway, ie, <250 ms; a preexcited RR interval
of

250 ms during spontaneous or pacing-induced AF episodes;
and fast AV reciprocating tachycardia associated with poor cardiac
output). In nonconclusive cases, reassessment using isoproterenol
infusion may be useful.
81 Patients with supraventricular tachycardia
but with a history of VF during exercise should be suspected
of having supraventricular tachycardia degenerating into VF,
because exercise enhances AV nodal conduction.
 |
Myocarditis
|
|---|
The strongest evidence that subclinical myocarditis can be a
cause of VF comes from an autopsy series
82 on US army recruits
in which 40% of those who died suddenly had histological evidence
of myocarditis. However, in those subjects who were ostensibly
normal before death, the status of ventricular function was
unknown. Therefore, the question remains whether myocarditis
can lead to VF when all other clinical parameters are normal.
The gold standard for the diagnosis of myocarditis remains myocardial biopsy (immunochemical stains are essential), which is highly specific.83 84 However, because of the patchy involvement of the myocardium, biopsies have a low sensitivity, and therefore a negative biopsy cannot be considered a definitive criterion for excluding myocarditis.85 86 87 In several cases, the origin of the arrhythmias defined during the electrophysiological study is not concordant with the site of histological abnormality; thus, it may be difficult to establish a causal relationship between bioptic findings and arrhythmias.
In the future, polymerase chain reaction gene amplification may allow identification of the viral genome from biopsy samples88 and may help in interpreting borderline findings.
 |
Infiltrative Diseases
|
|---|
Infiltrative diseases are generally detectable when major changes
of the myocardial structure have occurred. In patients with
sarcoidosis, a stepwise imaging investigation
89 could be performed
to exclude cardiac involvement. Myocardial biopsy should also
be considered for the diagnosis of sarcoidosis, even in the
absence of pulmonary evidence of the disease or a negative response
to a skin test.
 |
Minimal Diagnostic Requirements For the Diagnosis of IVF
|
|---|
On the basis of the criteria outlined above, a panel of tests
should be performed in patients with unexplained cardiac arrest
to exclude clinical conditions associated with sudden cardiac
death.
Although noninvasive tests might establish a diagnosis and avoid the need for invasive tests, the majority of patients without an obvious cause of cardiac arrest will undergo invasive testing (Table 1
).
 |
Recognition and Interpretation of Minimal Cardiac Abnormalities
|
|---|
One of the major steps in defining VF as "idiopathic" should
be to clarify possible causal relationships that are currently
unrecognized or controversial. In addition to nonspecific bioptic
findings, the significance of minor hemodynamic abnormalities,
such as borderline right and left ventricular indexes and subtle
wall motion abnormalities, is unclear in survivors of IVF. Furthermore,
the prevalence of subtle abnormalities in comparable individuals
without life-threatening arrhythmias is not known.
An example of a minor abnormality frequently encountered in normal individuals that may pose the question of a causal relationship with cardiac arrest is mitral valve prolapse. A causal relationship between mitral valve prolapse and sudden death has not been established unless the prolapse is associated with valve redundancy, thickening, and regurgitation; QT prolongation; or ST-T wave changes.90 91 92 93 94 95 General agreement exists that paroxysmal and chronic atrial fibrillations have no specific relation to sudden death in the absence of the Wolff-Parkinson-White syndrome or hyperthyroidism or in subjects <70 years old; however, at least one study96 showed that VT was easier to induce in the presence of atrial fibrillation than of sinus rhythm, and the Framingham study reported higher mortality in patients with chronic atrial fibrillation than in controls.97 This raises the possibility that lack of significant risk may relate to inadequate evaluation of the issue.
Partial AV block (first-degree AV block or temporary second-degree AV block not associated with marked bradycardia), hypertension without LVH, and age >60 years as independent factors are not associated with sudden death and thus may be compatible with the diagnosis of IVF.
Similarly, isolated, modest thickening of the septum or free wall of the left ventricle (<10% greater than normal), regional dyskinesia, and isolated bundle-branch block do not identify a specific cause or association with sudden death and may therefore be considered compatible with the diagnosis of IVF.
RBBB associated with persistent ST-segment elevation has recently been defined as a form of IVF.24 However, evidence by Corrado et al98 suggests that this syndrome might represent one spectrum of right ventricular cardiomyopathy. These authors showed that within one family with right ventricular dysplasia, some members showed the ST-segment displacement, while others had the typical "epsilon" wave.99 Until more data support this view, there is not enough evidence to consider RBBB and ST-segment displacement alone as diagnostic for ARVD; therefore, patients with only these features should be considered to have a variant of IVF, but careful evaluation of the right ventricle should be performed at follow-up (Table 2
).
Even though as of today it remains unclear whether patients with "absolutely no evidence of heart disease" differ from those with "some evidence of cardiac abnormality," it is important that any even minimal abnormality be recorded and followed over time to allow prospective evaluation of its prognostic value.
Finally, there are some clinical conditions that will be difficult or impossible to exclude despite careful investigations (Table 3
). For example, the interpretation of electrolyte disturbance in patients resuscitated from cardiac arrest is often equivocal because many patients are hypokalemic because of catecholamine release after the event. Thus, it is difficult to ascribe hypokalemia as a cause of IVF unless there is a history of electrolyte imbalance, the patients are receiving medications known to deplete potassium or are on liquid protein diets, or there is documentation of severe electrolyte abnormalities when the patient is in steady state.
The relationship between clinical findings and causation of cardiac arrest must take into account that there is a continuous spectrum from completely normal to the frankly abnormal. Judgment on the role of equivocal abnormalities in triggering or conditioning the cardiac arrest must be based on the severity of the abnormality and the strength of the evidence for a link between the abnormality and the occurrence of cardiac arrest. Moreover, abnormalities are not isolated in time: they may be transient or evolutionary and in the latter case may remain undetectable for a long time after the index clinical event.100
 |
Importance of Accurate Follow-up
|
|---|
Several findings may be present that cannot be considered sufficient
for a diagnosis but that, nonetheless, are suspicious and may
be forerunners of a structural heart disease that will become
apparent only with time. In these cases, although an initial
diagnosis of IVF may be acceptable, a careful follow-up of the
patient is necessary. Even in the absence of symptoms or of
arrhyth